Cargando…

Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis

Detalles Bibliográficos
Autor principal: Lee, Sang-Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604604/
https://www.ncbi.nlm.nih.gov/pubmed/23526871
http://dx.doi.org/10.3904/kjim.2013.28.2.159
_version_ 1782263767950688256
author Lee, Sang-Oh
author_facet Lee, Sang-Oh
author_sort Lee, Sang-Oh
collection PubMed
description
format Online
Article
Text
id pubmed-3604604
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-36046042013-03-22 Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis Lee, Sang-Oh Korean J Intern Med Editorial The Korean Association of Internal Medicine 2013-03 2013-02-27 /pmc/articles/PMC3604604/ /pubmed/23526871 http://dx.doi.org/10.3904/kjim.2013.28.2.159 Text en Copyright © 2013 The Korean Association of Internal Medicine http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Lee, Sang-Oh
Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
title Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
title_full Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
title_fullStr Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
title_full_unstemmed Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
title_short Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
title_sort patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604604/
https://www.ncbi.nlm.nih.gov/pubmed/23526871
http://dx.doi.org/10.3904/kjim.2013.28.2.159
work_keys_str_mv AT leesangoh patientstreatedwithatumornecrosisfactorainhibitoraremorelikelytodevelopextrapulmonarytuberculosis